KIT and ovarian carcinoma: In Fig. 5, we clearly demonstrated that c-Kit upregulates phospho-PHBY259 in the lipid raft domain to interact with the membrane-tethered Notch3 fragment and enhance the Notch3—PBX1 signaling pathway in ovarian cancer cells.